Matsumoto T, Yamada H
Oriental Medicine Research Center, Kitasato Institute, Tokyo, Japan.
J Pharm Pharmacol. 1995 Feb;47(2):152-6. doi: 10.1111/j.2042-7158.1995.tb05769.x.
The pectic polysaccharide, bupleuran 2IIb, up-regulates Fc-receptor (FcR) expression on peritoneal macrophages in a dose-dependent manner. The intracellular signal transduction by bupleuran 2IIb leading to the expression of FcR was studied. Neither the protein kinase C (PKC) inhibitor, 1-(5-isoquinolinylsulphonyl)-2-methylpiperazine dihydrochloride, nor the structurally distinct PKC antagonist, calphostin C, inhibited bupleuran 2IIb-induced up-regulation of FcR, whereas two direct activators of PKC, L-alpha-1-oleoyl-2-acetyl-sn-3-glycerol and N-(6-phenylhexyl)-5-chloro-1-naphthalenesulphonamide were unable to up-regulate the expression of FcR. The protein kinase A (PKA) inhibitor, N-[2-(methylamino)ethyl]-5-isoquinolinesulphonamide dihydrochloride also did not inhibit bupleuran 2IIb-induced up-regulation of FcR. Fluorescence image analysis using the calcium-sensitive dye, Fura-2, demonstrated that bupleuran 2IIb induced a rapid increase in intracellular levels of calcium (Ca2+). When macrophages were treated with calcium antagonist, 8-(diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride, bupleuran 2IIb-induced up-regulation of FcR was inhibited in a dose-dependent manner. The bupleuran 2IIb-induced up-regulation of FcR was also blocked by two structurally distinct calmodulin antagonists, trifluoperazine and N-(6-aminohexyl)-5-chloro-1-naphthalenesulphonamide hydrochloride. Furthermore, elevation of intracellular Ca2+ using the calcium ionophore, A23187, led to up-regulation of the FcR expression in a dose-dependent manner. These results suggest that bupleuran 2IIb induces the up-regulation of FcR on macrophages by a mechanism dependent on an increase in intracellular Ca2+ followed by activation of the calmodulin, but not by a PKC or PKA pathway.
果胶多糖柴胡皂苷2IIb以剂量依赖方式上调腹膜巨噬细胞上的Fc受体(FcR)表达。研究了柴胡皂苷2IIb导致FcR表达的细胞内信号转导。蛋白激酶C(PKC)抑制剂1-(5-异喹啉磺酰基)-2-甲基哌嗪二盐酸盐和结构不同的PKC拮抗剂钙泊三醇均未抑制柴胡皂苷2IIb诱导的FcR上调,而两种PKC直接激活剂L-α-1-油酰基-2-乙酰基-sn-3-甘油和N-(6-苯基己基)-5-氯-1-萘磺酰胺则无法上调FcR表达。蛋白激酶A(PKA)抑制剂N-[2-(甲氨基)乙基]-5-异喹啉磺酰胺二盐酸盐也未抑制柴胡皂苷2IIb诱导的FcR上调。使用钙敏染料Fura-2进行的荧光图像分析表明,柴胡皂苷2IIb诱导细胞内钙(Ca2+)水平迅速升高。当巨噬细胞用钙拮抗剂盐酸8-(二乙氨基)辛基-3,4,5-三甲氧基苯甲酸酯处理时,柴胡皂苷2IIb诱导的FcR上调以剂量依赖方式受到抑制。柴胡皂苷2IIb诱导的FcR上调也被两种结构不同的钙调蛋白拮抗剂三氟拉嗪和盐酸N-(6-氨基己基)-5-氯-1-萘磺酰胺阻断。此外,使用钙离子载体A23187升高细胞内Ca2+会导致FcR表达以剂量依赖方式上调。这些结果表明,柴胡皂苷2IIb通过依赖于细胞内Ca2+增加随后激活钙调蛋白的机制诱导巨噬细胞上FcR的上调,而不是通过PKC或PKA途径。